The Mission
NeuroFlamma began with a real family member whose brain inflammation kept spreading on MRI while every clinical test came back normal, and the diagnosis stayed out of reach.
A tool to help clinicians see patterns and narrow the differential faster — when time and certainty are scarce.
Neuroinflammation of the brain and spinal cord — multiple sclerosis, NMOSD, MOGAD, autoimmune encephalitis, infections and their mimics — can be subtle, evolving, and easy to misread. The clues are often in the MRI: where lesions sit, how they're shaped, how they change. NeuroFlamma is built to read those patterns against documented international criteria and surface the next decisive test — always as support for the treating physician.
It has since grown from an MS-focused tool into a whole-neuraxis, multi-disease platform: dedicated, calibrated models now read MS lesions, brain tumour, acute stroke, spinal-cord lesions and atrophy — across the brain and the spinal cord — so the differential and its key mimics are covered in one pass. The mission is unchanged: help the clinician see, decide, and never replace them.
بدأ المشروع من حالة إنسانية حقيقية: التهابٌ يتّسع في الدماغ على أشعة الرنين بينما كل التحاليل طبيعية، والتشخيص بعيد المنال. نيوروفلاما أداةٌ لمساعدة الأطباء على رؤية الأنماط وتضييق التشخيص التفريقي أسرع — دائماً كدعمٍ للطبيب المعالج لا بديلاً عنه.
Every output is decision-support, flagged for specialist review. NeuroFlamma never issues a final diagnosis and never speaks over the doctor.
We publish negative results, say which numbers are internal and not yet reproduced, and make the agent abstain when it isn't sure.
An auditable pipeline, hard safety gates, and zero tolerance for unsafe false-negatives on dangerous mimics (abscess, cord, HSV, meningitis).
Bilingual (Arabic & English), browser-based, no special hardware — so the help reaches the bedside, the lab, and the classroom.